Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan
· Delayed Price · Currency is TWD 40.45
-0.75 (-1.82%)
At close: Dec 5, 2025
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 13.30 billion as of December 5, 2025. Its market cap has increased by 5.22% in one year.
Market Cap
13.30B
Enterprise Value
11.92B
Revenue
594.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.45
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 13.30B, an increase of 369.06%. That is a compound annual growth rate of 16.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.37B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |